/Abbott%20Laboratories%20HQ%20photo-%20by%20Sundry%20Photography%20via%20iStock.jpg)
North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $196.2 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market and its products include pharmaceuticals, nutritional, diagnostics, and vascular products. The medical device manufacturer is expected to announce its fiscal fourth-quarter earnings for 2024 before the market opens on Wednesday, Jan. 22.
Ahead of the event, analysts expect ABT to report a profit of $1.34 per share on a diluted basis, up 12.6% from $1.19 per share in the year-ago quarter. The company has consistently beat or matched Wall Street’s EPS estimates in its last four quarterly reports.
